ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 19

$1.71M Total Retail Price of All Prescriptions

Rank: 4 out of 19

651 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 651 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

24% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 24,641 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 36.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 1,001 869 1 6
HYDROCODONE-ACETAMINOPHEN 976 788 S3 2 8
LISINOPRIL 972 816 3 7
FUROSEMIDE 883 819 4 2
DONEPEZIL HCL 883 875 4 9
LEVOTHYROXINE SODIUM 829 771 6 3
WARFARIN SODIUM 695 586 7 1
SERTRALINE HCL 687 584 8 18
NAMENDA 647 630 9 4
METOPROLOL TARTRATE 642 563 10 5
RISPERIDONE 594 579 11 27
CITALOPRAM HBR 592 543 12 13
SIMVASTATIN 585 509 13 15
MIRTAZAPINE 423 378 14 17
GABAPENTIN 409 331 15 10
DIVALPROEX SODIUM 391 278 16 16
POTASSIUM CHLORIDE 361 305 17 11
ESCITALOPRAM OXALATE 343 310 18 12
ATORVASTATIN CALCIUM 336 241 19 33
METFORMIN HCL 309 212 20 20
OLANZAPINE 295 265 21 49
LEVETIRACETAM 286 251 22 35
LEVEMIR FLEXPEN 283 253 23 83
CARVEDILOL 268 246 24 22
QUETIAPINE FUMARATE 254 245 25 30
HYDROCHLOROTHIAZIDE 239 196 26 32
CIPROFLOXACIN HCL 232 203 27 55
FAMOTIDINE 232 205 27 36
RANITIDINE HCL 226 192 29 21
OMEPRAZOLE 219 195 30 14
IPRATROPIUM-ALBUTEROL 209 202 31 31
BACLOFEN 203 132 32 71
TRAMADOL HCL 199 176 33 23
LANTUS 197 162 34 29
JANTOVEN 187 164 35 19
ISOSORBIDE MONONITRATE ER 186 184 36 40
DIOVAN 182 182 37 51
PREDNISONE 182 159 37 28
NOVOLOG FLEXPEN 177 142 39 44
DILTIAZEM 24HR CD 169 168 40 107
PRAVASTATIN SODIUM 165 148 41 25
CYMBALTA 165 143 41 37
PHENYTOIN SODIUM EXTENDED 164 107 43 76
NOVOLOG 162 137 44 60
DIGOXIN 158 158 45 47
ATENOLOL 155 143 46 54
TAMSULOSIN HCL 151 144 47 39
LANTUS SOLOSTAR 150 123 48 69
LEVOFLOXACIN 149 138 49 52
EXELON 149 149 49 26
GLIPIZIDE 135 128 51 42
LEVEMIR 134 97 52 65
SANTYL 132 99 53 99
METOPROLOL SUCCINATE 131 121 54 50
FLUOXETINE HCL 128 128 55 109
ZOLPIDEM TARTRATE 127 98 56 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 127 111 56 62
NEXIUM 122 81 58 43
HYDRALAZINE HCL 116 98 59 66
CEPHALEXIN 112 110 60 41
KLOR-CON M20 111 98 61 79
NOVOLIN R 107 97 62 73
LACTULOSE 104 101 63 119
FENTANYL 104 90 S2 63 70
TRAZODONE HCL 102 91 65 24
SPIRONOLACTONE 101 80 66 93
LATANOPROST 100 92 67 86
CLONIDINE HCL 100 86 67 84
VENLAFAXINE HCL ER 99 73 69 94
ALENDRONATE SODIUM 96 96 70 104
HUMULIN R 94 63 71 124
TIMOLOL MALEATE 94 94 71 175
PROMETHAZINE HCL 93 86 R 73 72
SPS 93 52 73 134
SEROQUEL 92 91 75 64
LOSARTAN POTASSIUM 88 71 76 58
HALOPERIDOL 87 67 77 103
BENZTROPINE MESYLATE 86 18 R 78 80
ALLOPURINOL 86 86 78 59
CLOPIDOGREL 85 77 80 38
HUMALOG 83 47 81 95
TRAVATAN Z 80 70 82 91
BRIMONIDINE TARTRATE 79 62 83 140
LYRICA 78 65 84 113
SPIRIVA 78 71 84 98
NITROFURANTOIN 73 47 86 114
DILTIAZEM 24HR ER 72 67 87 105
FLUTICASONE PROPIONATE 71 50 88 77
PLAVIX 69 59 89 67
NEOMYCIN-POLYMYXIN B 69 0 10 89 191
FINASTERIDE 68 68 91 192
ZETIA 67 55 92 160
CARBIDOPA-LEVODOPA 67 56 92 61
GENERLAC 66 34 94 198
HUMULIN 70-30 62 62 95 205
PERMETHRIN 61 61 96 207
KLOR-CON M10 60 48 97 92
LEXAPRO 59 59 98 48
ENALAPRIL MALEATE 59 59 98 111
DOXYCYCLINE HYCLATE 59 48 98 75
VENLAFAXINE HCL 59 59 98 131
CRESTOR 59 59 98 125
OXYCODONE HCL 59 44 S2 98 127
NITROFURANTOIN MONO-MACRO 58 54 104 100
MORPHINE SULFATE 58 57 S2 104 132
RIVASTIGMINE 57 57 106 121
CLONIDINE 57 57 106 118
MELOXICAM 54 54 108 90
POLYETHYLENE GLYCOL 3350 54 46 108 34
DILTIAZEM ER 54 49 108 154
OXYCODONE-ACETAMINOPHEN 53 46 S2 111 123
ALBUTEROL SULFATE 53 51 111 45
ROPINIROLE HCL 53 52 111 88
ABILIFY 52 18 114 78
RENVELA 52 0 114 226
LIPITOR 52 49 114 165
ACTOS 51 44 117 229
LAMOTRIGINE 51 50 117 229
PROPRANOLOL HCL 50 38 119 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.